Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Thus, our study defines highly conserved protein features of circulating EVs in human plasma (Table 1 highlights the top 25 EV or NonEV protein features; asterisks indicate surface-accessible proteins).List of EV and NonEV protein featuresGene symbolProtein nameGO (CC | BP)ReferenceEV protein featuresADAM10*Disintegrin and metalloproteinase domain-containing protein 10Cell membrane, endomembrane | Adherens junction organization112ARPC4*Actin-related protein 2/3 complex subunit 4Cell projection, cytoskeleton | Actin filament polymerization113CD47*Leukocyte surface antigen CD47Cell membrane | Integrin-mediated signalling pathway114F11R*Junctional adhesion molecule ACell membrane | Actomyosin structure organization115VCP*Transitional endoplasmic reticulum ATPaseCytoplasm, ER | ER-to-Golgi vesicle-mediated transport116STXBP2Syntaxin-binding protein 2Cytosol | Vesicle docking involved in exocytosis117RAC1*Ras-related C3 botulinum toxin substrate 1Cell membrane (lipid anchor) | Actin cytoskeleton organization118ACTR2*Actin-related protein 2Cell projection, cytoskeleton | Arp2/3 complex-mediated actin nucleation119EHD1*EH domain-containing protein 1Early/Recycling endosome | Endocytic recycling120FLOT1*Flotillin-1Cell membrane, endosome | Plasma membrane raft assembly121CAPN1*Calpain-1 catalytic subunitCell membrane, cytoplasm | Regulation of catalytic activity122ITGA2*Integrin alpha-2Membrane | Cell adhesion123NAPA*Alpha-soluble NSF attachment proteinPeripheral membrane protein | Apical protein localization124RAB7A*Ras-related protein Rab-7aLipid anchor, late endosome | Endosome to plasma membrane transport125FLOT2Flotillin-2Cell membrane, endosome | Plasma membrane raft126ARPC3*Actin-related protein 2/3 complex subunit 3Cell projection, cytoskeleton | Actin polymerization127ARPC2*Actin-related protein 2/3 complex subunit 2Cell junction, cell projection | Actin filament polymerization128GNA13Guanine nucleotide-binding protein subunit alpha-13Membrane (lipid anchor) | Rho protein signal transduction129LYNTyrosine-protein kinase LynCell membrane | Cell adhesion mediated by integrin130CYFIP1Cytoplasmic FMR1-interacting protein 1Cell projection | Actin filament polymerization131ACTR3Actin-related protein 3Cell projection, cytoskeleton | Cell motility119PRKAR1AcAMP-dependent protein kinase type I-alpha regulatory subunitCell membrane | G protein-coupled receptor signalling132SNAP23*Synaptosomal-associated protein 23Cell membrane (lipid-anchor) | Membrane fusion133PDCD6IPProgrammed cell death 6-interacting proteinCytoplasm, cytoskeleton | Multivesicular body assembly134ANXA11Annexin A11Cytoplasm, cytoskeleton | Phagocytosis135NonEV protein featuresC6Complement component C6Secreted | Complement activation136F10Coagulation factor XSecreted | Blood coagulation137C7Complement component C7Secreted | Complement activation138CPB2Carboxypeptidase B2Secreted | Blood coagulation136SERPING1Plasma protease C1 inhibitorSecreted | Complement activation139F13BCoagulation factor XIII B chainSecreted | Fibrin clot formation140APOA4Apolipoprotein A-IVSecreted | Lipid transport141F2ProthrombinSecreted | Blood coagulation136TF*SerotransferrinSecreted | Iron ion transport142ORM1*Alpha-1-acid glycoprotein 1Secreted | Acute-phase response136APOB*Apolipoprotein B-100Secreted | Lipoprotein transport136SERPINC1Antithrombin-IIISecreted | Blood coagulation143CFIComplement factor ISecreted | Complement activation144CLEC3BTetranectinSecreted | Bone mineralization145AFMAfaminSecreted | Vitamin transport146AZGP1*Zinc-alpha-2-glycoproteinSecreted | Immune response147GC*Vitamin D-binding proteinSecreted | Vitamin transport148TTR*TransthyretinSecreted | Purine nucleobase metabolic process148SERPINA3*Alpha-1-antichymotrypsinSecreted | Lipid metabolic process149AHSG*Alpha-2-HS-glycoproteinSecreted | Bone mineralization145HPXHaemopexinSecreted | Haem metabolic process150A1BGAlpha-1B-glycoproteinSecreted145ITIH3Inter-alpha-trypsin inhibitor heavy chain H3Secreted | Hyaluronan metabolic process148RBP4Retinol-binding protein 4Secreted | Retinol transport151SERPINF1Pigment epithelium-derived factorSecreted | Cellular response to retinoic acid152
Source: Defining the core protein features of circulating EVs. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
SW480 (CCL-288, ATCC), SW620 (CCL-227, ATCC) and LIM1863 cells (Ludwig Institute for Cancer Research, Melbourne) cells were cultured in RPMI-1640 (Life Technologies).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma
Study design awaiting verification · Nature Cell Biology · 2025
Original publication title
Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Extracellular vesicles (EVs) are an essential signalling entity in human plasma implicated in health and disease. Still, their core protein and lipid componentry, which lie at the centre of EV form and function, remain poorly defined. Here we performed high-resolution density gradient fractionation of over 140 human plasma samples to isolate circulating EVs, and systematically constructed their quantitative proteome (4,500 proteins) and lipidome (829 lipids) landscapes using mass spectrometry. We identified a highly conserved panel of 182 proteins (including ADAM10, STEAP23 and STX7) and 52 lipids (including PS, PIPs, Hex2Cer and PAs), providing a deep survey of hallmark molecular features and biological pathways characteristic to circulating EVs.
We also mapped the surfaceome diversity, identifying 151 proteins on the EV surface. We further established a set of 42 proteins and 114 lipids features that served as hallmark features of non-EV particles in plasma. We submit ADAM10 and PS(36:1) as conserved EV biological markers that precisely differentiate between EV and non-EV particles. Our findings, which can be explored via an open-source Shiny web tool (evmap.shinyapps.io/evmap/), will serve as a valuable repository to the research community for a clearer understanding of circulating EV biology.
The composition of extracellular vesicles (EVs) is central to their function, yet the field lacks systematic characterization. Here Rai et al. perform proteomic and lipidomic analyses of circulating human plasma EVs and create a web tool for data exploration.
Authors’ abstract
Extracellular vesicles (EVs) are an essential signalling entity in human plasma implicated in health and disease. Still, their core protein and lipid componentry, which lie at the centre of EV form and function, remain poorly defined. Here we performed high-resolution density gradient fractionation of over 140 human plasma samples to isolate circulating EVs, and systematically constructed their quantitative proteome (4,500 proteins) and lipidome (829 lipids) landscapes using mass spectrometry. We identified a highly conserved panel of 182 proteins (including ADAM10, STEAP23 and STX7) and 52 lipids (including PS, PIPs, Hex2Cer and PAs), providing a deep survey of hallmark molecular features and biological pathways characteristic to circulating EVs.
We also mapped the surfaceome diversity, identifying 151 proteins on the EV surface. We further established a set of 42 proteins and 114 lipids features that served as hallmark features of non-EV particles in plasma. We submit ADAM10 and PS(36:1) as conserved EV biological markers that precisely differentiate between EV and non-EV particles. Our findings, which can be explored via an open-source Shiny web tool (evmap.shinyapps.io/evmap/), will serve as a valuable repository to the research community for a clearer understanding of circulating EV biology.
The composition of extracellular vesicles (EVs) is central to their function, yet the field lacks systematic characterization. Here Rai et al. perform proteomic and lipidomic analyses of circulating human plasma EVs and create a web tool for data exploration.
Publication and source details
Original title: Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma
Alin Rai; Kevin Huynh; Jonathon Cross; Qi Hui Poh; Haoyun Fang; Bethany Claridge; Thy Duong; Carla Duarte; Jonathan E. Shaw; Thomas H. Marwick; Peter Meikle; David W. Greening
Nature Cell Biology · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100000925Department of Health | National Health and Medical Research Council (NHMRC)MRF2015523APP1141946GNT1197190Huynh Kevin Greening David W. https://doi.org/10.13039/501100001030National Heart Foundation of Australia (Heart Foundation)105072Greening David W.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:32:39.436061+00:00
DOI: 10.1038/s41556-025-01795-7 · PMC12717007